 |
市場調查報告書
拋棄式注射器的全球市場:2020-2027年Global Disposable Syringes Market - 2020-2027 |
||||||
| 出版商 | DataM Intelligence | 商品編碼 | 955731 | ||||
| 出版日期 | 按訂單生產 | 內容資訊 | 英文 商品交期: 請詢問到貨日 |
||||
| 價格 |
|
||||||
| 拋棄式注射器的全球市場:2020-2027年 Global Disposable Syringes Market - 2020-2027 | ||
| 出版日期: 按訂單生產 | 內容資訊: 英文 |
|
拋棄式注射器市場，由於對拋棄式注射器的使用的興趣提高各種NGO的活動增加，抑制HIV等疾病擴大的必要性，及注射劑的需求高漲，而受到促進。注射劑直接進入全身循環，更快生效提供所需的效果。 另外，越來越多的針刺傷病例增加了對安全注射器的需求。這些好處有助於增加注射劑的使用量，從而促進全球一次性注射器市場的成長。
本報告提供全球拋棄式注射器市場相關調查，市場概要，各市場區隔及各地區的市場規模的預測，主要企業的簡介，競爭情形分析等系統性資訊。
A syringe which is designed for one time use and is discarded after the use is called as a disposable syringe. Furthermore, a syringe is defined as a sterile cylindrical medical instrument which has a thin hollow needle at the end. In addition, this device acts as a pump, which is used to draw therapeutic liquid formulation from vials and deliver them to the blood stream of a patient. However within more modern times the disposable syringe has risen in popularity over the traditional reusable syringe. The primary difference being that a disposable syringe is intended for one-time use and is then disposed of, typically into a contamination unit.
Different syringes will take on different sizes dependent on whether they are being used for injection, tubing, or irrigation. This is due to the relationship of volume and pressure. Smaller syringes (1 - 10ml) are typically used to inject medication into a patient while large syringes (20 - 70ml) with higher volume are typically used for irrigation. Most medium sized syringes which occupy the territory of 10 to 12ml are used for tubing, such as with catheters and other medical tubing's.
The market is driven by the increasing number of activities by various NGO's that create awareness for the use of disposable syringes, need to control the spread of diseases like HIV, and rising demand of injectable drugs.
There has been a marked increase in the use of injectable drugs, primarily due to the lack of bioavailability in conventional drug delivery methods. A large number of orally administered drugs are subject to decomposition during the first-pass metabolism, which renders them ineffective by the time they reach the systemic circulation. On the other hand, injectable drugs directly enter the systemic circulation and provide the desired effect with the quicker onset of action. Furthermore, there are rising cases of needle stick injuries are driving the demand for the safety syringes. These advantages are also responsible for increased adoption of injectable drug and the consequent growth of the global disposable syringes market. Furthermore, the increasing demand for vaccines is expected to drive the sales of syringes particularly disposable syringes in the developing regions of the world.
Sustained growth of the injectable drugs sector, which primarily includes biologics, is the major factor driving the global disposable syringes market. More than 60% drugs in clinical development are biologics. This indicates strong growth of the biologics market. In turn, this is expected to boost the disposable syringes market. Rise in demand for point-of-care administration and technological advancements in the manufacturing of disposable syringes are fueling the global disposable syringes market.
Groundbreaking innovations such as the introduction of two-step disposable autoinjector devices are bolstering the growth of the global disposable syringes market. Companies in the market for disposable syringes are increasing efforts to introduce devices that cater to different viscosities in drugs. They are increasing focus to deliver design improvements in devices that are eliminating the need for customizing system components. Novel two-step disposable autoinjector devices are overcoming challenges of breakage and incompatibility associated with poorly integrated systems.
However, high cost of safety disposable syringes restricts market growth. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.
With the COVID-19 pandemic outbreak, the demand of disposable syringes is increasing due to the medication of infected patients. The companies has increased their production so that there is no shortage of disposable syringes to the hospitals. This factor will drive the growth of the market in the forecast period.
The global disposable syringes market is segmented based on product by conventional disposable syringes, safety disposable syringes, needles, oral syringes, and filling needles. The safety disposable syringes segment held the largest market share due to reducing needle stick injuries. The most notable difference between a safety syringe and its standard counterpart is the presence of a plastic shield which surrounds the needle and locks into place once the needle has been used. Most safety syringes also include plastic sheaths that can be opened and closed. This allows for safe transport and storage of the syringe during patient care. Further, these types of sheaths allow for safe disposal of the needle and removal of used needles from the health care facility.
While the introduction of universal precautions and safety-conscious needle designs has led to a decline in such type of injuries. Awareness of needle stick injuries started to develop soon after the identification of HIV and today the major concern after a needle stick injury is not HIV but hepatitis B or hepatitis C. The safety syringes can be segmented into retractable safety syringes and non-retractable safety syringes. A safety syringe is equipped with a sheath that automatically extends over the needle of the syringe after the syringe has been used to administer the injection. Safety syringes can help in the prevention of transmission of diseases, like AIDS and Hepatitis, among healthcare workers. Additionally, safety syringes help to avert all types of needle stick injuries.
According to the WHO, 3 million accidental needle-stick injuries were reported in 2003, with 37% new hepatitis B cases in health care workers, 39% of new hepatitis C cases, and around 5.5% of new HIV cases. Moreover, around 422 million people had diabetes across the world in 2016. Increase in health care spending, rise in prevalence of blood borne diseases, and surge in awareness about the benefits of safety syringes drive the global safety syringes market.
The oral syringes segment is expected to have positive market growth in the forecast period. Oral syringes are used to deliver medication orally directly in the mouth of the patient. They are designed in such a way that it reduces the risk of medication dosing thus curbing chances of administrative error. Oral syringes can meet patient needs of all the age groups, and this syringes can be used several times by an individual patient within a time frame of seven days. Parent market for oral syringes is the medical syringes with a needle and some possible related markets for oral syringes are injection pens, specialty needles, and insulin pumps. Over the years, the market has evolved from using dosing cups, droppers and the use of teaspoon while consuming liquid medication to the use of oral syringes to increase chances of giving correct doses.
As there is a growing prevalence of acute diseases caused due to improper amount of consumption of doses thus the need for accurate consumption of medication has increased leading to the growth of oral syringes segment across the world. Oral syringes are easy to use and can also be pre-sterilized so that it can be re-used and also helps in reducing the drug losses. These all factors together drive the oral syringe segment.
Further, the market is also classified based on application as immunization injections, and therapeutic injections. Therapeutic injections are joint injections administered for the relief of chronic pain and inflammation. They are used in patients who are experiencing either acute or chronic discomfort but are usually reserved for patients who have not achieved desirable relief from more conservative measures like physical therapy. There are several types of therapeutic joint injections, the most common of which are steroidal injections. Many injections are designed to provide immediate relief following the injections, as well as slow-release treatment over the course of several weeks or months after the injection.
The therapeutic injections segment is expected to have positive market growth due to the growing demand for injectable to treat diseases. According to the WHO, around 90% of products are used for therapeutic care. Treatment of diabetes by delivering insulin comprises a large share in therapeutic injections. High prevalence of diseases such as HIV infection, malaria, tuberculosis, and dengue results in high consumption of injections, which are used in the diagnosis and treatments of these diseases.
Introduction of new injectable drugs is also expected to augment the industry growth. In August 2015, CytoDyn, Inc. announced the initiation of a clinical trial of their injectable HIV drug. This injectable was expected to replace the daily antiretroviral pill dose with a once-a-week injection, thus improving the quality of life of the 33 million people living with AIDS
The immunization injections is expected to have positive market growth in the forecast period. Immunizations injections protects from serious diseases and also prevent the spread of those diseases to others. Over the years immunizations injections have thwarted epidemics of once common infectious diseases such as measles, mumps, and whooping cough.
According to the UNICEF in May 2020, 99 countries reported the termination of the immunization campaigns for measles, polio, meningococcal, DTP, and many other antigens. This factor will drive the growth of the segment in the forecast period.
By region, the global disposable syringes market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global disposable syringes market and is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of the market include rising cases of diabetes and the presence of better healthcare infrastructure. As per American Diabetes Association (ADA), in 2017, around 34.2 million Americans, who account for nearly 10.5% of the population, had diabetes and approximately 1.6 million American children and adults had type 1 diabetes. Taking insulin is an important management technique for millions who have diabetes and the most common method for insulin delivery in the United States is injection with the help of a syringe.
Furthermore, there is a rising prevalence of chronic diseases in the United States which is helping the market to grow in the region. Thus, owing to the all the mention factors the market is expected to witness high growth over the forecast period.
The Asia-Pacific region is expected to have third-largest share due improving economic conditions, rise in purchasing power of the people, the growth in awareness regarding the advantages of prefilled syringes, and the presence of a large patient pool suffering from various chronic diseases are expected to drive the market. In Asia-Pacific, Japan accounts for the major share of the market by revenue as well as volume, owing to the increased demand for self-administered treatments and high penetration of self-injection devices, growing the aging population, and increasing the prevalence of diabetes.
The global disposable syringes market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, Henke-Sass Wolf, Nipro Medical Corporation, Novo Nordisk A/S, Retractable Technologies, Inc., are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.
The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for the dental implants across the globe. For instance, in October 2016, B Braun scheduled launch of its echogenic peripheral nerve block needle technology, the Stimuplex Ultra 360. The launch was to be presented in the American Society of Anesthesiologists Annual Meeting.
*The global disposable syringes market report will provide access to approximately 60 market data tables, 47 figures, and 200 pages.
